UniQuest & PMI collaborate to develop non-addictive pain killers
Date: 2018-01-31   Author: Saipriya Iyer  Category: #industry

UniQuest & PMI collaborate to develop non-addictive pain killers

UniQuest Private Limited, a commercialization unit of the University of Queensland, has apparently signed on a research & option pact with PrevCeutical Medical Incorporation (PMI). Incidentally, PMI, a Canada based biomedical firm, has been a part of this agreement for carrying out research on non-addictive analgesics.

UniQuest plausibly aims to promote the use of peptide disulphide linker technology for developing non-addictive pain killers. According to the CEO of UniQuest, the university is planning to develop a drug other than opioids to avoid pain and use it as a suitable alternative for codeine. Researchers claim that the efforts to introduce alternative methods of pain treatment will certainly help in addressing the global opioid drug overdose issues.

As per reports, the Australian government has decided to prohibit the sale of over-the-counter analgesics with codeine as one of its ingredients from 1st February this year. The new legislation may, in all likelihood, boost the research for developing non-addictive analgesics in the ensuing years. One of the research scientists at the University of Queensland has even gone on record to state that UniQuest had signed four agreements with PMI over the past few months. He further claimed that the joint research to develop non-addictive pain-killing drugs is inclusive of peptide synthesis & testing for their pain killing activity, in addition to its pharmacological & pharmacokinetic assessment in chronic medical conditions.

It has been quoted that earlier in April 2017, UniQuest and PMI had agreed to develop stable peptides for boosting immune system. Sources cite that in the same month both the firms had jointly declared of creating a soluble gel that can transport cannabinoids to the brain through nasal cavity. In the third agreement taking place between the two firms in July last year, it has apparently been reported that they would conduct a joint research program as well, to develop a gene therapy for effectively treating obesity & diabetes.



About Author


Saipriya Iyer

Saipriya Iyer

Saipriya Iyer currently works as a content developer for AlgosOnline. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her belt, she has dabbled with website...

Read More

More from Saipriya


Post Recommendents

Foam Tray Market Size Outlook 2025: Top Companies, Trends, Growth Factors Details by Regions, Types and Applications
Author: Partha Ray

This is a professional and in-depth study on the current state of the Foam Tray Market. Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores in...


On-board Wireless Sensor Market Size, Growth, Analysis, Outlook by 2020 - Trends, Opportunities and Forecast to 2025
Author: Partha Ray

Global On-board Wireless Sensor Market 2019 Includes Market Size, Share, Trends, Growth, Demand, Supply, Application, Segmentation, Opportunity, Market Development, Production, Capacity Utilization, Supply, Analysis and Forecast by 2024

.


Waste Incinerators Market Size, Latest Trend, Growth by Size, Application and Forecast 2025
Author: Partha Ray

Market Study Report LLC adds a new report on Waste Incinerators Market Share for 2019-2024. This report provides a succinct analysis of the market size, revenue forecast, and the regional landscape of this industry. The report also highlights the ...